Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn whether a muraglitazar-metformin
combination is at least as effective as a glimepiride-metformin combination to treat type 2
diabetics who are not sufficiently controlled with metformin alone. The safety of this
treatment will also be studied.